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ABSTRACT 
The aim of this study was to investigate the effect of red wine consumption on the lipid profile and glucose in the group of 
male (13 men aged 34 – 64 years) and the group of female (11 women aged 28 – 57 years). Research consisted of moderate 
red wine consumption for 6 weeks. The dose of alcohol ranged from 200 to 300 mL per day of red wine Lemberger 
(Winery Masaryk, Slovakia). The blood samples were obtained after overnight fasting and were collected at baseline and 
after three days, three weeks and six weeks of wine consumption. Differences between male and female subjects were 
reflected in the results of different biochemical parameters in the dynamics of wine consumption. We found out that while 
in females the total cholesterol level did not change significantly and had a predominantly downward trend, for male 
subjects we observed at the beginning the slight increase of the levels, which, however, after 6 weeks of consumption 
significantly decreased from an initial value of 5.75 ±1.32 mmol.L-1 to 5.35 ±1.25 mmol.L-1 (p <0.05). The blood 
concentration of triglycerides in the dynamics of the experiment did not change significantly in either one gender, although 
small differences were observed, because while the female subjects had triglyceride development over consumption 
upward trend in male subjects it was vice versa. LDL-cholesterol changed significantly only in the group of female. Level 
of this lipid parameter decreased significantly during the six weeks of consumption of Lemberger from an initial value 
3.37 ±0.68 mmol.L-1 to the lowest 2.99 ±0.61 mmol.L-1, which was recorded in the third week of consumption (p <0.0001), 
but statistically significant differences versus baseline we monitored after three days and six weeks of consumption 
(p <0.01). In the group of male, we did not observe such significant changes, but it should be noted, that the men had 
changes in LDL-cholesterol downward direction and all the values were in the range of benchmarks. In the group of 
female, HDL-cholesterol increased to 2.05 ±0.6 mmol.L-1 after six weeks of consumption from baseline of 1.7 ±0.69 
mmol.L-1, and the difference was statistically significant (p <0.05), in the group of male, its level changed first significantly 
after three days of consumption of steep increase (1.46 ±0.61 mmol.L-1, p <0.05), and for the next six weeks, it was the 
significantly increase (1.59 ±0.5 mmol.L-1, p <0.01). The glucose concentration did not change significantly in the 
dynamics of wine consumption among men and women, and all the values were between the limits of the standard. 
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INTRODUCTION 
 Among the wine experts as the best wines in the world 
they consider French, Italian and German white wines. 
Slovak vineyards also offer a wide range of wine grape 
varieties from which it is possible to produce high-quality 
and fine wines. Even the results of our measurements 
confirm (Gažarová et al., 2008), the Slovak dry red and 
white wines contain health-promoting substances which 
are not only comparable with quality foreign wines, but in 
some cases, greater than. It is proved by the content of the 
total polyphenols, especially specific substances such as 
trans-resveratrol, quercetin and anthocyanins in red wines. 
In addition, Slovak wines have significant anti-radical 
capabilities, which allow them to compete with high-
quality foreign wines. 
 Various mechanisms are involved in the development of 
fatal and non-fatal coronary heart diseases and other 
vascular diseases, including inflammatory and oxidative 
stress, that leading to hypertension, diabetes and other risk 
factors that accelerate atherosclerosis. The creation of 
conditions preventing the overproduction of a toxic 
accumulation of free radicals becomes the foundation for 
both the prophylaxis and also in enhancing the 
effectiveness of treatment of lifestyle and civilization 
diseases including cardiovascular diseases. Red wine 
provides alcohol and polyphenolic compounds. The 
beneficial effects of moderate red wine consumption may 
be attributed to the overall mix of its components and not 
to one in particular – the alcoholic fraction increases HDL-
cholesterol, non-alcoholic fraction (polyphenolic 
compounds) inhibits the oxidation of LDL particles, 
improvements of endothelial function, blood lipid profile 
and decreases blood pressure (Tsang et al., 2005; Karatzi 
et al., 2009; Xin et al., 2010; Costanzo et al., 2011). 
 In the last decades, wine is the subject of various studies, 
while it is monitored not only the short-term but also the 
long-term effects of wine consumption in the relation to 
the various diseases. Many of these studies not only 
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suggest but even confirm the beneficial effects of wine on 
human health compared to other alcoholic beverages. Also 
other authors (Renaud and de Lorgeril, 1992; Mosinger, 
1994; Marques-Vidal et al., 1995; Carbonneau et al., 
1998; Serafini et al., 1998; Paganga et al., 1999; 
Gorinstein et al., 2000; Gronbaek et al., 2000; Klatsky 
et al., 2003; Renaud et al., 2004) share the same opinion 
based on their research, that among the alcoholic 
beverages the red wine is the most effective against 
atherosclerosis.  
 Numerous epidemiological studies observed a J-shaped 
relationship between increasing wine consumption and 
cardiovascular risk (Fuller, 2011; Rostron, 2012), low 
HDL-cholesterol, high triglycerides (Park and Kim, 
2012). Meta-analyses of cohort studies confirmed a U-
shaped relationship between alcohol intake and type-2 
diabetes (Koppes et al., 2005; Baliunas et al., 2009). 
Moderate alcohol consumption is up to 30 g alcohol.day-1 
for men and 10 – 15 g alcohol.day-1 for women. Different 
amounts of alcohol have different health benefits 
according to gender. Some studies suggest that the 
beneficial effects of alcohol consumption are higher in 
men than in women (Xin et al., 2001), but many studies 
show similar effects in both genders (Mukamal et al., 
2005). Lorková et al., (2015) found that the most 
preferred alcoholic beverages among men were beer and 
wine and among women wine and liqueurs. The regular 
use of alcohol was reported by 55.35% of men and 33.4% 
of women consume 0.2 – 0.5 liters of alcoholic beverage 
per week. Bellavia et al., (2014) found that women with 
alcohol intake of 5 – 10 g.day-1 had lower risk of 
cardiovascular diseases and cancer mortality and men with 
alcohol consumption of 15 – 20 g.day-1 had lower only risk 
of cardiovascular diseases mortality. 
 At some stage of life, male´s and female´s organism 
works under the influence of several different factors. This 
can be mostly reflected the different health based on 
gender. In the case of civilization diseases, one gender is 
more prone to one type of disease, while the opposite 
gender turns into a different type of diseases. 
Morphologically and physiologically there are some 
differences between the genders that can play an important 
role in the development and predisposition to certain 
diseases. Framingham study data showed a lower 
incidence of cardiovascular disease events among 
premenopausal women compared with postmenopausal 
women (Kannel, Hjortland and McNamara 1976). 
Premenopausal women represent a specific part of the 
population due to the effect of female sex hormone 
estrogen, which protect them from the cardiovascular 
disease by reducing this risk, while in the case of male sex 
hormones androgens opposite is true. It means that 
premenopausal women are on average at substantially 
lower risk of premature cardiovascular disease than men of 
the same age. An adverse effect of menopause on 
cardiovascular diseases risk is explained by the 
deterioration of the lipid profile towards postmenopause 
(Matthews et al., 2009). This is reflected in increasing 
levels of total cholesterol, LDL-cholesterol and 
triglycerides and the reduction of HDL-cholesterol 
(Anagnostis et al., 2015). 
 Since the consumption of alcoholic beverages is 
associated with the risk of both cardiovascular and other 
civilization diseases, it seems interesting to observe the 
effect of the consumption of the Slovak dry red wine 
Lemberger to the individual biochemical, anthropometric 
and clinical indicators depending on gender. Based on this 
fact, we investigated the effect on female subjects, and 
especially in male subjects. 
  
MATERIAL AND METHODOLOGY 
 The aim of this study was to investigate the effect of red 
wine consumption on the lipid profile and glucose in the 
group of male and the group of female. Research consisted 
of moderate red wine consumption. 1 – 3 glasses of red 
wine at dinner after day of abstinence were administered to 
24 healthy volunteers (13 men aged 34 – 64 years - mean 
age 51 years and 11 women aged 28 – 57 years - mean age 
45 years) for 6 weeks. The dose of alcohol ranged from 
200 to 300 mL per day of red wine Lemberger (Winery 
Masaryk, Slovakia). Most of the subjects were categorized 
in the group at high risk for cardiovascular complications. 
The participants were carefully instructed to abstain from 
any pharmacological treatment and all of the volunteers 
were asked to maintain their habitual diets and lifestyles 
during the 6 weeks of the study. The blood samples were 
obtained after overnight fasting and were collected at 
baseline (1st blood sampling) and after three days (2nd 
blood sampling), three weeks (3rd blood sampling) and six 
weeks (4th blood sampling) of wine consumption. Serum 
and EDTA-plasma were collected and stored at the 
temperature -80 °C. A total fasting blood sample was 
collected to assess a total cholesterol, low-density 
lipoprotein (LDL-C), high-density lipoprotein (HDL-C), 
triglyceride and glucose. A written informed consent to 
participate in the study was provided to all subjects 
involved in the study after they were informed of all risks, 
discomforts and benefits. The Ethic Committee at the 
Specialized Hospital St. Zoerardus Zobor, n. o. approved 
the study protocol. All the biochemical parameters were 
analyzed at the Department of Human Nutrition at Slovak 
University of Agricultural using the selective 
multiparameter analyzer LISA 200. The results were 
evaluated with standard mathematical-statistical methods 
(STATISTICA Cz, MS Excel 2007). Differences were 
tested with the t-test, Tukey and Fisher test. The results 
were listed in the Table 1 and Table 2. 
 
RESULTS AND DISCUSSION 
 Differences between male and female subjects were also 
reflected in the results of different biochemical parameters 
in the dynamics of wine consumption. Cholesterol is one 
of the basic compounds essential for cells life. Its blood 
concentration is relatively stable through dietary intake 
restrictions, a change in its concentration evident only after 
a long time. The reference values for the optimum 
cholesterol levels range from 3 to 5.2 mmol.L-1. In the 
lipid profile, we found out that while in females the total 
cholesterol level did not change significantly and had a 
predominantly downward trend, for male subjects we 
observed at the beginning the slight increase of the levels, 
which, however, after 6 weeks of consumption statistically 
significant decreased from an initial value of 5.75 ±1.32 
mmol.L-1 to 5.35 ±1.25 mmol.L-1 (p <0.05). For both, male 
and female group, the total cholesterol levels remained 
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above the upper limit of normal reference values. Similar 
results reached the authors Basu et al., (2006). 
 Triglycerides do not interfere in the process of 
atherogenesis, but the elevated levels point at the increased 
levels of fatty substances and certain lipoproteins in the 
blood. The optimum range of blood triglyceride values is 
from 0.2 to1.92 mmol.L-1. The blood concentration of 
triglycerides in the dynamics of the experiment did not 
change significantly in either one gender, although small 
differences were observed, because while the female 
subjects had triglyceride development over consumption 
upward trend in male subjects it was vice versa. It is also 
important to stress that while triglyceride levels in women 
ranged within the normal range, men had all values above 
the upper critical threshold. The negative effect of alcohol 
consumption is the increase in triglycerides. Cesena et al., 
(2011) reported that red wine increased plasma levels of 
triglycerides and the triglycerides/HDL-C ratio and those 
individuals with higher BMI were at higher risk for 
elevation in plasma triglycerides. Although fasting levels 
of triglyceride have been shown to increase in some 
experimental observations, the change is minor compared 
with increases in HDL (Leighton and Urquiaga, 2007). 
 To determine the risk of atherosclerosis it is not as 
important total cholesterol, but in particular the binding to 
the various types of lipoproteins and their concentrations 
in blood. It is proved the direct dependence between serum 
levels of LDL-cholesterol and mortality from 
cardiovascular diseases. The optimal level of LDL-
cholesterol is in the range from 0 to 3.9 mmol.L-1. In the 
cardiovascular prevention the reduction of LDL-C by 1% 
results in a reduction in the risk of coronary heart disease 
by 1%. Every reduction in LDL-C by 1 mmol.L-1 
(~40 mg.dL-1) leads to the corresponding 22% reduction in 
cardiovascular mortality and morbidity in patients with 
risk. In general, the US national recommendations advise 
the following reference values for serum lipids: (total 
cholesterol <200 mg.dL-1, triglycerides <150 mg.dL-1, 
LDL-C <130 mg.dL-1 and HDL-C >40 mg.dL-1). 
Extrapolated from the clinical studies overall reduction in 
LDL-cholesterol below <1.8 mmol.L-1 (less than 
~70 mg.dL-1), or at least 50% has the largest benefit in 
terms of the decrease of cardiovascular diseases. In 
patients with a very high cardiovascular risk is the 
therapeutic target of LDL-C value <1.8 mmol.L-1 or more 
than 50% decrease from baseline. In patients with high 
cardiovascular risk a target LDL blood value is 
<2.5 mmol.L-1 and in patients with moderate risk 
<3 mmol.L-1 (ESC Pocket Guidelines). In our study, 
LDL-cholesterol changed significantly only in the group of 
female. Level of this lipid parameter significantly 
decreased during the six weeks of consumption of 
Lemberger from an initial value 3.37 ±0.68 mmol.L-1 to 
the lowest 2.99 ±0.61 mmol.L-1, which was recorded in the 
third week of consumption (p <0.0001), but statistically 
significant differences versus baseline we monitored after 
three days and six weeks of consumption (p <0.01). In the 
group of male, we did not observe such significant 
changes, but it should be noted, that the men had changes 
in LDL-cholesterol downward direction and all the values 
were in the range of benchmarks. Kanner et al., (2012) 
found that LDL-C was slightly reduced after red wine 
consumption. The same decline also observed Shai et al., 
(2004); Micallef, Lexis and Lewandowski (2007) and 
Joosten et al., (2008).  
 HDL-cholesterol is considered to be a long-term 
protective factor for the development of cardiovascular 
diseases. The total level of HDL-C is inversely associated 
with the risk of the developing coronary heart disease and 
an increase in HDL-C by 0.39 mmol.L-1 results in a risk 
reduction by 22%, and every increase in HDL-C by 1% 
results in a reduction in the risk of coronary heart disease 
by 2 – 3% (Sabaka et al., 2012). When we assessed 
changes in levels of "good" HDL-C in the dynamics of 
consumption of Lemberger we found out that values were 
changed very beneficially in both genders in the direction 
of a positive increase, but in group of male reflected these 
changes significantly. In the group of female, HDL-C 
increased to 2.05 ±0.6 mmol.L-1 after six weeks of 
consumption from baseline of 1.7 ±0.69 mmol.L-1, and the 
difference was statistically significant (p <0.05), in the 
group of male, its level changed first significantly after 
three days of consumption of steep increase (1.46 ±0.61 
mmol.L-1, p <0.05), and for the next six weeks, it was the 
significantly increase (1.59 ±0.5 mmol.L-1, p <0.01). This 
positive upturn described most authors dealing with this 
topic (Gaag et al., 1999; Estruch, 2000; Devaraj et al., 
2002; Shai et al., 2004; Sierksma et al., 2004; Joosten et 
al., 2008). Brien et al., (2011) reported that moderate red 
wine consumption increased HDL-C. Leighton et al., 
(2000) showed that 30 g of alcohol a day would cause an 
average increase of 8.3% in HDL levels. Leighton and 
Urquiaga (2007) observed increases in HDL-C ranging 
between 4% and 18% among wine consumers and red 
wine appeared to be slightly better than white wine. 
 Although women should be more protected against 
cardiovascular risk, but there are also other factors to 
eliminate this benefit of women, for example diabetes 
mellitus. In this regard, monitoring of the impact of dry red 
wine intake on blood glucose changes has been very 
interesting. After evaluating the results we observed that 
the level of glucose in the dynamics of consumption did 
not change significantly in either men or women and that 
all the values were between the limits of the standards. 
After 3 days of wine consumption we observed a slight 
increase in its levels in both genders, which in the next 
weeks in women returned back to the level of initial value 
(4.93 ±0.45 mmol.L-1 vs baseline 4.91 ±0.47 mmol.L-1) 
and in men even lower (5.54 ±0.91 mmol.L-1 of 
5.72 ±0.87 mmol.L-1). A U-shaped relationship between 
alcohol consumption and risk of type-2 diabetes has been 
confirmed (Koppes et al., 2005; Baliunas et al., 2009). 
Several studies have suggested that moderate alcohol 
intake reduces the risk of type-2 diabetes by 20 – 40% 
(Joosten et al., 2010; Sato et al., 2012; Shi et al., 2013). 
Rasouli et al., (2013) reported that high consumers had 
similar risk to abstainers. Heianza et al., (2013) reported a 
higher risk of type-2 diabetes among binge drinkers and 
Cullmann, Hilding and Ostenson (2012) found a higher 
type-2 diabetes risk among heavy consumers. Chiva-
Blanch et al., (2013) found that red wine with or without 
alcohol improved metabolism of glucose. Rasouli et al., 
(2013) found that consumption of wine has been linked to 
reduced diabetes risk.  
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CONCLUSION 
 As mentioned above and in many other researches it is 
therefore clear that wine is much richer in content of 
nutrients and natural products beneficial for the human 
body than expected. Its consumption, if it is drunk sensibly 
and in moderation, is not harmful to the human body and 
forms an appropriate part of the diet and is beneficial for 
health. It should be taken into consideration that the 
moderate consumption of alcohol is recommended to the 
healthy people. It is necessary to fight against excessive 
and inappropriate consumption of alcoholic beverages and 
therefore the wine and it is needed to drink it in 
moderation. Although everyone has different opinions on 
what is moderate drinking, the fact is that wine is fine, and 
therefore deserves the noble usage and use only to the 
extent that it has a pleasant effect and benefit to our body 
and strengthened the health because drinking too much 
wine is harmful to the human body! 
 We found out that during consumption of red wine the 
serum of total cholesterol did not change significantly and 
had a predominantly downward trend in the group of 
female. In the group of male, we initially observed a slight 
increase in the levels, which after 6 weeks of consumption 
statistically significantly decreased. Total cholesterol 
levels in both genders, we found above the upper range of 
reference values. The level of triglycerides in the dynamics 
of the experiment did not change significantly in either one 
gender, although there were observed small differences. In 
female subjects had changed in triglycerides upward trend, 
in male subjects it was just the opposite. In contrast to 
women, in men all values of triglycerides were above the 
upper limit of normal. LDL-cholesterol was significantly 
changed only in women whose levels decreased 
significantly. Changes in LDL-cholesterol in group of 
male had downward direction, although statistically not 
significant, and all the values were in the range of 
benchmarks. HDL-cholesterol in both genders in the 
dynamic of consumption of Lemberger was changed very 
favorably in the direction of a positive increase, but in 
male subjects reflected to these changes significantly. 
Women should be more protected against cardiovascular 
disease, but there are impacts that eliminate this benefit of 
women, such as diabetes mellitus. Diabetes increases the 
risks of heart attack, stroke and other complications of the 
atherosclerosis in women much more than in men. It is 
therefore favorable fact that the glucose concentration did 
not change significantly in the dynamics of wine 
consumption among men and women, and all the values 
were between the limits of the standard. 
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